Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2012-003137-41Phase 2Completed
A Phase 2 trial of eslicarbazepine acetate in epilepsy, sponsored by BIAL. Started Mar 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2012-003137-41.